OmniLit Acquisition (OLITW) Competitors $0.05 0.00 (-2.50%) As of 03/31/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsSEC FilingsTrendsBuy This Stock OLITW vs. HTGMQ, PRENW, QSIAW, SMAPW, TT, KEYS, FTV, VLTO, TER, and RVTYShould you be buying OmniLit Acquisition stock or one of its competitors? The main competitors of OmniLit Acquisition include HTG Molecular Diagnostics (HTGMQ), Prenetics Global (PRENW), Quantum-Si (QSIAW), SportsMap Tech Acquisition (SMAPW), Trane Technologies (TT), Keysight Technologies (KEYS), Fortive (FTV), Veralto (VLTO), Teradyne (TER), and Revvity (RVTY). These companies are all part of the "measuring and control equipment" industry. OmniLit Acquisition vs. HTG Molecular Diagnostics Prenetics Global Quantum-Si SportsMap Tech Acquisition Trane Technologies Keysight Technologies Fortive Veralto Teradyne Revvity HTG Molecular Diagnostics (NASDAQ:HTGMQ) and OmniLit Acquisition (NASDAQ:OLITW) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, institutional ownership, analyst recommendations, risk, valuation, community ranking, media sentiment, dividends and profitability. Does the MarketBeat Community prefer HTGMQ or OLITW? HTG Molecular Diagnostics and OmniLit Acquisition both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformHTG Molecular DiagnosticsN/AN/AOmniLit AcquisitionN/AN/A Is HTGMQ or OLITW more profitable? Company Net Margins Return on Equity Return on Assets HTG Molecular DiagnosticsN/A N/A N/A OmniLit Acquisition N/A N/A N/A Which has better earnings & valuation, HTGMQ or OLITW? OmniLit Acquisition has lower revenue, but higher earnings than HTG Molecular Diagnostics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHTG Molecular Diagnostics$6.37M0.00-$21.59MN/AN/AOmniLit AcquisitionN/AN/AN/AN/AN/A Does the media favor HTGMQ or OLITW? In the previous week, HTG Molecular Diagnostics' average media sentiment score of 0.00 equaled OmniLit Acquisition'saverage media sentiment score. Company Overall Sentiment HTG Molecular Diagnostics Neutral OmniLit Acquisition Neutral SummaryHTG Molecular Diagnostics beats OmniLit Acquisition on 1 of the 1 factors compared between the two stocks. Remove Ads Get OmniLit Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for OLITW and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OLITW vs. The Competition Export to ExcelMetricOmniLit AcquisitionShell Companies IndustryFinance SectorNASDAQ ExchangeMarket CapN/A$31.41M$11.32B$7.86BDividend YieldN/A4.81%5.39%4.05%P/E RatioN/A0.5422.6218.67Price / SalesN/A457.0725.6087.31Price / CashN/A196.4417.6134.64Price / BookN/A92.082.704.09Net IncomeN/A-$141.08M$1.03B$246.93M7 Day PerformanceN/A0.36%-0.69%-3.79%1 Month PerformanceN/A0.11%498.37%-6.74%1 Year PerformanceN/A3.36%535.88%-1.88% OmniLit Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OLITWOmniLit AcquisitionN/A$0.05-2.5%N/A-62.9%$0.00N/A0.003HTGMQHTG Molecular DiagnosticsN/AN/AN/AN/A$0.00$6.37M0.0090PRENWPrenetics GlobalN/A$0.01+7.2%N/A+68.8%$0.00$25.56M0.001Positive NewsGap DownQSIAWQuantum-SiN/A$0.43-3.3%N/A+65.2%$0.00$3.06M0.00150Gap UpSMAPWSportsMap Tech AcquisitionN/A$0.07-4.7%N/A+73.4%$0.00N/A0.00N/ATTTrane Technologies4.4988 of 5 stars$346.58-1.6%$413.69+19.4%+12.3%$77.74B$19.84B30.8139,000Positive NewsKEYSKeysight Technologies4.3035 of 5 stars$155.38-0.7%$184.44+18.7%-4.1%$26.85B$5.02B44.3915,000Insider TradeShort Interest ↓FTVFortive4.226 of 5 stars$74.66-0.7%$87.18+16.8%-14.8%$25.41B$6.23B31.6318,000News CoveragePositive NewsVLTOVeralto3.6677 of 5 stars$98.05+0.3%$113.50+15.8%+10.0%$24.27B$5.19B29.3516,000Short Interest ↓Positive NewsTERTeradyne4.9838 of 5 stars$85.68-2.6%$121.44+41.7%-26.8%$13.86B$2.82B25.736,500Short Interest ↓Positive NewsRVTYRevvity3.5038 of 5 stars$107.41+0.0%$136.25+26.9%+0.8%$12.90B$2.76B48.6011,500News CoveragePositive News Remove Ads Related Companies and Tools Related Companies HTG Molecular Diagnostics Alternatives Prenetics Global Alternatives Quantum-Si Alternatives SportsMap Tech Acquisition Alternatives Trane Technologies Alternatives Keysight Technologies Alternatives Fortive Alternatives Veralto Alternatives Teradyne Alternatives Revvity Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:OLITW) was last updated on 4/1/2025 by MarketBeat.com Staff From Our PartnersTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredRetirement Nightmare? It’s Already Happening.The market is on edge. Every day, another company slashes its dividend, leaving investors scrambling. Intel...Investors Alley | SponsoredNew “Trump” currency proposed in DCA former U.S. Presidential Advisor has come forward with a stern warning to investors: “Get out of tech, no...Paradigm Press | SponsoredBrace Yourself for Jeff Bezos’ “Amazon Helios”Jeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical t...Stansberry Research | SponsoredIs Fort Knox Hiding Less Gold Than We Think? Find Out What That Means for YouWith gold prices recently soaring to record highs over $3,000 an ounce, and central banks rushing to accumulat...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OmniLit Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share OmniLit Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
